REVERSE MERGER (Narrative) (Details) - USD ($)			1 Months Ended	12 Months Ended
	Feb. 12, 2018	Jun. 29, 2017	Aug. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Sep. 06, 2018
Business Combination Segment Allocation [Line Items]
Number of shares converted (in shares)			1,735,419
Number of shares converted from debt instrument (in shares)	1,814,754
Shares converted, value		$ 3,000,000
Conversion of debt into stock	$ 1,900,000			$ 3,191,000
New shares issued (in shares)	1,814,754		22,518
Common stock, shares outstanding (in shares)				34,481,083	10,196,620	23,155,872
Convertible Debt [Member]
Business Combination Segment Allocation [Line Items]
Conversion of debt into stock				$ 2,356,000	$ 1,787,000
Debt instrument, face amount		$ 800,000
Private Placement
Business Combination Segment Allocation [Line Items]
New shares issued (in shares)		107,056
Consideration received		$ 400,000
Common Stock
Business Combination Segment Allocation [Line Items]
Number of shares converted (in shares)		5,352,847
Number of shares converted from debt instrument (in shares)		1,414,700		3,787,300
Preferred Stock [Member]
Business Combination Segment Allocation [Line Items]
Number of shares converted (in shares)		7,155
Number of shares converted from debt instrument (in shares)		802,920
Share price (in dollars per share)		$ 12.20
Preferred Stock [Member] | Private Placement
Business Combination Segment Allocation [Line Items]
New shares issued (in shares)		107,056
Transgenomics
Business Combination Segment Allocation [Line Items]
Merger transaction, effective date		Jun. 29, 2017
Conversion of debt into stock		$ 3,000,000
Stock price used for estimating purchase consideration (in dollars per share)		$ 6.80
Common stock, shares outstanding (in shares)		895,334
Preferred stock, dividend rate (percentage)		8.00%
Transgenomics | Common Stock
Business Combination Segment Allocation [Line Items]
Number of shares converted from debt instrument (in shares)		352,630
Conversion of debt into stock		$ 3,000,000
Transgenomics | Preferred Stock [Member]
Business Combination Segment Allocation [Line Items]
Number of shares converted (in shares)		7,155
Number of shares converted from debt instrument (in shares)		802,925
Conversion of debt into stock		$ 3,000,000